SANOFI TO BOOST TRANSPLANT WITH KADMON PURCHASE

The latest big-ticket acquisition was announced just a month after the French drugmaker disclosed another billion-dollar deal. Shares of Sanofi fell, however, following the news, while Kadmon’s stock climbed to a five-year high.

ADSS Review

Thursday, 09 Sep, 2021 / 7:53

About the Author

You may also like these